While testicular cancer is a rare form of cancer, with only 8,800 cases diagnosed within the U.S. each year, it is the most common form of cancer in young men, ages 18-35.
Symptoms of testicular cancer include a lump or firmness in the testicle, swelling or enlargement of the testicle (with or without pain) and/or pain or a dull ache in the area.
It is important for men to do regular self-examinations to check for any lumps, swelling or changes in the testicles, just as women are recommended to do regular self breast exams.
Fortunately, if detected early, testicular cancer has a nearly 100 percent cure rate.
In most early stage cases of testicular cancer, surgery is often curative and the only form of treatment needed. Depending on the tumor, some or all of the testicle will be removed during surgery.
The procedure does not affect a man’s ability to have sexual intercourse, and prosthetic testicles are available for cosmetic reconstruction.
If detected in later stages, surgery, along with chemotherapy and radiation therapy, may be needed to treat testicular cancer.
At Cone Health Cancer Center, a multidisciplinary team of urologists, surgeons, medical and radiation oncologists, and other related medical professionals work together to develop the best possible treatment plan for each patient that is seen at the Center.
Dr. Matthew Eskridge is a urologist at Alliance Urology and a member of the Cone Health medical staff.
Dr. Eskridge is a 2003 graduate of Wake Forest University School of Medicine.
He completed his residency in urology at Medical University of South Carolina in 2006.